We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says It Will Sic the FTC on Endo for Attempts to Block Generic Versions of Its Drug
FDA Says It Will Sic the FTC on Endo for Attempts to Block Generic Versions of Its Drug
The FDA has called out Endo International, maker of Vasostrict, saying the agency plans to ask the Federal Trade Commission (FTC) to investigate Endo for “anticompetitive business practices” after the company pressed FDA to block generics of its best-selling drug.